Mowad Theresa G, Willett Aimee E, Mahmoudian Mani, Lipin Mikhail, Heinecke Armin, Maguire Albert M, Bennett Jean, Ashtari Manzar
Department of Ophthalmology, Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, PA, United States.
The Edward Via College of Osteopathic Medicine, Blacksburg, VA, United States.
Front Neurosci. 2020 May 12;14:291. doi: 10.3389/fnins.2020.00291. eCollection 2020.
Sensory deprivation prompts extensive structural and functional reorganizations of the cortex resulting in the occupation of space for the lost sense by the intact sensory systems. This process, known as cross-modal plasticity, has been widely studied in individuals with vision or hearing loss. However, little is known on the neuroplastic changes in restoring the deprived sense. Some reports consider the cross-modal functionality maladaptive to the return of the original sense, and others view this as a critical process in maintaining the neurons of the deprived sense active and operational. These controversial views have been challenged in both auditory and vision restoration reports for decades. Recently with the approval of Luxturna as the first retinal gene therapy (GT) drug to reverse blindness, there is a renewed interest for the crucial role of cross-modal plasticity on sight restoration. Employing a battery of task and resting state functional magnetic resonance imaging (rsfMRI), in comparison to a group of sighted controls, we tracked the functional changes in response to auditory and visual stimuli and at rest, in a group of patients with biallelic mutations in the gene ("RPE65 patients") before and 3 years after GT. While the sighted controls did not present any evidence for auditory cross-modal plasticity, robust responses to the auditory stimuli were found in occipital cortex of the RPE65 patients overlapping visual responses and significantly elevated 3 years after GT. The rsfMRI results showed significant connectivity between the auditory and visual areas for both groups albeit attenuated in patients at baseline but enhanced 3 years after GT. Taken together, these findings demonstrate that (1) RPE65 patients present with an auditory cross-modal component; (2) visual and non-visual responses of the visual cortex are considerably enhanced after vision restoration; and (3) auditory cross-modal functions did not adversely affect the success of vision restitution. We hypothesize that following GT, to meet the demand for the newly established retinal signals, remaining or dormant visual neurons are revived or unmasked for greater participation. These neurons or a subset of these neurons respond to both the visual and non-visual demands and further strengthen connectivity between the auditory and visual cortices.
感觉剥夺会促使皮层发生广泛的结构和功能重组,导致完好的感觉系统占据因丧失感觉而空出的空间。这一过程被称为跨模态可塑性,已在视力或听力丧失的个体中得到广泛研究。然而,对于恢复被剥夺感觉时的神经可塑性变化却知之甚少。一些报告认为跨模态功能对原始感觉的恢复具有不良适应性,而另一些报告则将其视为维持被剥夺感觉的神经元活跃和正常运作的关键过程。几十年来,这些有争议的观点在听觉和视觉恢复报告中都受到了挑战。最近,随着Luxturna作为首个用于治疗失明的视网膜基因疗法(GT)药物获批,人们对跨模态可塑性在视力恢复中的关键作用重新产生了兴趣。与一组视力正常的对照者相比,我们利用一系列任务和静息态功能磁共振成像(rsfMRI),追踪了一组双等位基因 基因发生突变的患者(“RPE65患者”)在接受GT治疗前和治疗后3年对听觉和视觉刺激以及静息状态下的功能变化。虽然视力正常的对照者没有表现出任何听觉跨模态可塑性的证据,但在RPE65患者的枕叶皮层中发现了对听觉刺激的强烈反应,这些反应与视觉反应重叠,并且在GT治疗3年后显著增强。rsfMRI结果显示,两组的听觉和视觉区域之间均存在显著的连通性,尽管患者在基线时连通性减弱,但在GT治疗3年后增强。综上所述,这些发现表明:(1)RPE6患者存在听觉跨模态成分;(2)视力恢复后,视觉皮层的视觉和非视觉反应显著增强;(3)听觉跨模态功能并未对视力恢复的成功产生不利影响。我们推测,在接受GT治疗后,为了满足新建立的视网膜信号需求,剩余或休眠的视觉神经元会被激活或解除抑制,从而更多地参与其中。这些神经元或其中的一部分神经元对视觉和非视觉需求均有反应,并进一步加强听觉和视觉皮层之间的连通性。